NEW YORK CITY — On a Tuesday that bridged the gap between the morning commute and a...
Patient Advocacy and Support
OTTAWA – As the landscape of oncology shifts toward increasingly personalized medicine, a comprehensive new national survey...
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) The landscape of medical treatment is...
NEW YORK — As the morning sun filtered through the iconic arched windows of Grand Central Terminal,...
Introduction: The Critical Need for Stage IV Representation In the complex landscape of oncological research and healthcare...
NEW YORK CITY — In a powerful demonstration of the intersection between public advocacy and scientific rigor,...
October, Breast Cancer Awareness Month, paints our world in shades of pink. From ubiquitous product promotions to...
TORONTO — A landmark national survey released by Breast Cancer Canada has unveiled a profound public consensus:...
Main Facts: A Quarter-Century of Impact in Cancer Surveillance Lori Swain, MS, stands as one of the...
By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have surged...
